Search Results - "HARRIS, Shannon L"

Safety, immunogenicity, and tolerability of meningococcal serogroup B bivalent recombinant lipoprotein 2086 vaccine in healthy adolescents: a randomised, single-blind, placebo-controlled, phase 2 trial by Richmond, Peter C, Dr, Marshall, Helen S, MBBS, Nissen, Michael D, MBBS, Jiang, Qin, MS, Jansen, Kathrin U, PhD, Garcés-Sánchez, Maria, MD, Martinón-Torres, Federico, PhD, Beeslaar, Johannes, MD, Szenborn, Leszek, MD, Wysocki, Jacek, MD, Eiden, Joseph, MD, Harris, Shannon L, PhD, Jones, Thomas R, PhD, Perez, John L, MD

“…Summary Background Neisseria meningitidis serogroup B is a major cause of invasive meningococcal disease, but a broadly protective vaccine is not currently…”
Get full text

Predicting the Susceptibility of Meningococcal Serogroup B Isolates to Bactericidal Antibodies Elicited by Bivalent rLP2086, a Novel Prophylactic Vaccine by McNeil, Lisa K, Donald, Robert G K, Gribenko, Alexey, French, Roger, Lambert, Nathaniel, Harris, Shannon L, Jones, Thomas R, Li, Sheng, Zlotnick, Gary, Vogel, Ulrich, Claus, Heike, Abad, Raquel, Vazquez, Julio A, Borrow, Ray, Findlow, Jamie, Taha, Muhamed-Kheir, Deghmane, Ala-Eddine, Caugant, Dominique A, Kriz, Paula, Musilek, Martin, Wang, Xin, Vuong, Jeni, Mayer, Leonard W, Pride, Michael W, Jansen, Kathrin U, Anderson, Annaliesa S

“…Bivalent rLP2086 (Trumenba), a vaccine for prevention of serogroup B (NmB) disease, was licensed for use in adolescents and young adults after it was…”
Get full text

Meningococcal serogroup B-specific responses after vaccination with bivalent rLP2086: 4 year follow-up of a randomised, single-blind, placebo-controlled, phase 2 trial by Marshall, Helen S, Dr, Richmond, Peter C, MBBS, Beeslaar, Johannes, MD, Jiang, Qin, MS, Jansen, Kathrin U, PhD, Garcés-Sánchez, Maria, PhD, Martinón-Torres, Federico, PhD, Szenborn, Leszek, MD, Wysocki, Jacek, Prof, Eiden, Joseph, MD, Harris, Shannon L, PhD, Jones, Thomas R, PhD, Lee, Su-San, BSc, Perez, John L, MD

“…Summary Background Bivalent rLP2086 is a recombinant factor H binding protein-based vaccine approved in the USA for prevention of meningococcal serogroup B…”
Get full text

Copper-Dependent Iron Transport in Coastal and Oceanic Diatoms by Maldonado, Maria T., Allen, Andrew E., Chong, Joanne S., Lin, Kevin, Leus, Dan, Karpenko, Nataliya, Harris, Shannon L.

“…We investigated the presence of plasmalemma-bound copper-containing oxidases associated with the inducible iron (Fe) transport system in two diatoms of the…”
Get full text

Meningococcal serogroup B vaccines: Estimating breadth of coverage by Donald, Robert G. K., Hawkins, Julio Cesar, Hao, Li, Liberator, Paul, Jones, Thomas R., Harris, Shannon L., Perez, John L., Eiden, Joseph J., Jansen, Kathrin U., Anderson, Annaliesa S.

“…Neisseria meningitidis serogroup B (MenB) is an important cause of invasive meningococcal disease. The development of safe and effective vaccines with activity…”
Get full text

Interlaboratory Reproducibility of Standardized Hemagglutination Inhibition Assays by Bibby, David C, Savanovic, Michael, Zhang, Jinrong, Torelli, Alessandro, Jeeninga, Rienk E, Gagnon, Luc, Harris, Shannon L

“…The hemagglutination inhibition (HI) assay is a prominent and commonly accepted method used to determine quantitative antibody titers for influenza virus…”
Get full text

On selecting a probabilistic classifier for appointment no-show prediction by Harris, Shannon L., Samorani, Michele

“…Appointment no-shows are disruptive to healthcare clinics, and may increase patient waiting time and clinic overtime, resulting in increased clinic costs…”
Get full text

MenB-FHbp Vaccine Protects Against Diverse Meningococcal Strains in Adolescents and Young Adults: Post Hoc Analysis of Two Phase 3 Studies by Beeslaar, Johannes, Absalon, Judith, Anderson, Annaliesa S., Eiden, Joseph J., Balmer, Paul, Harris, Shannon L., Jones, Thomas R., O’Neill, Robert E., Pregaldien, Jean-Louis, Radley, David, Maansson, Roger, Ginis, John, Srivastava, Amit, Perez, John L.

“…Introduction Two phase 3 studies in adolescents and young adults demonstrated that MenB-FHbp, a meningococcal serogroup B (MenB) vaccine, elicits protective…”
Get full text

Nutrient dynamics in a highly managed reservoir system: considering anadromous sockeye salmon (Oncorhynchus nerka) and nutrient restoration by Scott, David C., Harris, Shannon L., Hebert, Allison S., van Poorten, Brett T.

“…Scott DC, Harris SL, Hebert AS, van Poorten BT. 2017. Nutrient dynamics in a highly managed reservoir system: considering anadromous sockeye salmon…”
Get full text

Improving care transitions with standardized peer mentoring: Evidence from intervention based research using randomized control trial by Chun, Yeojun, Harris, Shannon L., Chandrasekaran, Aravind, Hill, Kristen

“…We investigate how patients can co‐create value when transitioning care between the hospital and home after a major life altering surgery such as kidney…”
Get full text

Preclinical evidence for the potential of a bivalent fHBP vaccine to prevent Neisseria meningitidis Serogroup C Disease by Harris, Shannon L., Zhu, Duzhang, Murphy, Ellen, McNeil, Lisa K., Wang, Xin, Mayer, Leonard W., Harrison, Lee H., Jansen, Kathrin U., Anderson, Annaliesa S.

“…A bivalent factor H binding protein (fHBP) vaccine for the prevention of disease caused by Neisseria meningitidis serogroup B is currently in clinical…”
Get full text

Thermodynamics and Density of Binding of a Panel of Antibodies to High-Molecular-Weight Capsular Polysaccharides by Harris, Shannon L, Fernsten, Philip

“…Classifications Services CVI Citing Articles Google Scholar PubMed Related Content Social Bookmarking CiteULike Delicious Digg Facebook Google+ Mendeley Reddit…”
Get full text

Predictive analytics model for healthcare planning and scheduling by Harris, Shannon L., May, Jerrold H., Vargas, Luis G.

“…•We model appointment no-show behavior based upon a patient's past history.•We determine how much of a patient's past history is necessary to provide…”
Get full text

A Bivalent Meningococcal B Vaccine in Adolescents and Young Adults by Ostergaard, Lars, Vesikari, Timo, Absalon, Judith, Beeslaar, Johannes, Ward, Brian J, Senders, Shelly, Eiden, Joseph J, Jansen, Kathrin U, Anderson, Annaliesa S, York, Laura J, Jones, Thomas R, Harris, Shannon L, O’Neill, Robert, Radley, David, Maansson, Roger, Prégaldien, Jean-Louis, Ginis, John, Staerke, Nina B, Perez, John L

“…In two phase 3 studies, a bivalent meningococcal B vaccine was shown to elicit serum bactericidal activity against 14 meningococcal B test strains in…”
Get full text

The effect of cancelled appointments on outpatient clinic operations by Harris, Shannon L., May, Jerrold H., Vargas, Luis G., Foster, Krista M.

“…•Develop a multi-day scheduling model that includes inter- and intra-day waiting.•Our solution approach optimizes the model without resorting to…”
Get full text

The bivalent factor H binding protein meningococcal serogroup B vaccine elicits bactericidal antibodies against representative non-serogroup B meningococci by Harris, Shannon L., Tan, Cuiwen, Andrew, Lubomira, Hao, Li, Liberator, Paul A., Absalon, Judith, Anderson, Annaliesa S., Jones, Thomas R.

“…•FHbp expression is not restricted to serogroup B strains of N. meningitidis.•Protection against non-MenB strains by antibodies elicited by the MenB-FHbp…”
Get full text

Persistence and 4-year boosting of the bactericidal response elicited by two- and three-dose schedules of MenB-FHbp: A phase 3 extension study in adolescents by Vesikari, Timo, Østergaard, Lars, Beeslaar, Johannes, Absalon, Judith, Eiden, Joseph J., Jansen, Kathrin U., Jones, Thomas R., Harris, Shannon L., Maansson, Roger, Munson, Samantha, O'Neill, Robert E., York, Laura J., Perez, John L.

“…The period of heightened risk of invasive meningococcal disease in adolescence extends for >10 years. This study aimed to evaluate persistence of the immune…”
Get full text

Persistence of hSBA titers elicited by the meningococcal serogroup B vaccine menB-FHbp for up to 4 years after a 2- or 3-dose primary series and immunogenicity, safety, and tolerability of a booster dose through 26 months by Østergaard, Lars, Vesikari, Timo, Senders, Shelly D., Flodmark, Carl-Erik, Kosina, Pavel, Jiang, Han-Qing, Maguire, Jason D., Absalon, Judith, Jansen, Kathrin U., Harris, Shannon L., Maansson, Roger, Balmer, Paul, Beeslaar, Johannes, Perez, John L.

“…•The need for protection from IMD extends through adolescence and young adulthood.•Immunogenicity and safety through 26 months post MenB-FHbp boosting were…”
Get full text

Avidity of the Immunoglobulin G Response to a Neisseria meningitidis Group C Polysaccharide Conjugate Vaccine as Measured by Inhibition and Chaotropic Enzyme-Linked Immunosorbent Assays by Harris, Shannon L, Tsao, How, Ashton, Lindsey, Goldblatt, David, Fernsten, Philip

“…Classifications Services CVI Citing Articles Google Scholar PubMed Related Content Social Bookmarking CiteULike Delicious Digg Facebook Google+ Mendeley Reddit…”
Get full text

Instructional Approaches: Anatomy Education of Physical Therapists by Simons, Ashley C., McHugh, Kirk M., Appling, Susan, Harris, Shannon L., Burgoon, Jennifer M.

“…The profession of physical therapy has undergone an evolution since its inception. Since the early 1900s it has grown from a technical training program to a…”
Get full text